Gene: RFX2
Official Full Name: regulatory factor X2provided by HGNC
Gene Summary: This gene is a member of the regulatory factor X gene family, which encodes transcription factors that contain a highly-conserved winged helix DNA binding domain. The protein encoded by this gene is structurally related to regulatory factors X1, X3, X4, and X5. It is a transcriptional activator that can bind DNA as a monomer or as a heterodimer with other RFX family members. This protein can bind to cis elements in the promoter of the IL-5 receptor alpha gene. Two transcript variants encoding different isoforms have been described for this gene, and both variants utilize alternative polyadenylation sites. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35646 | RFX2 Knockout cell line (HeLa) | Human | RFX2 | 1:3~1:6 | Negative | Online Inquiry |
KO35647 | RFX2 Knockout cell line (HCT 116) | Human | RFX2 | 1:2~1:4 | Negative | Online Inquiry |
KO35648 | RFX2 Knockout cell line (HEK293) | Human | RFX2 | 1:3~1:6 | Negative | Online Inquiry |
KO35649 | RFX2 Knockout cell line (A549) | Human | RFX2 | 1:3~1:4 | Negative | Online Inquiry |
RFX2 Gene Knockout Cell Lines are specialized cellular models that have been engineered to lack the RFX2 gene. This gene plays a critical role in the regulation of gene expression, particularly in the immune response, by affecting the transcription of major histocompatibility complex (MHC) class II molecules. The knockout of RFX2 allows researchers to study its functions in a controlled environment, providing insights into its contributions to various biological processes, including immune system functionality and cellular signaling pathways.
The primary function of the RFX2 Gene Knockout Cell Lines lies in their ability to facilitate detailed investigations into the immunological ramifications of RFX2 deficiency. These lines exhibit altered expression patterns of MHC class II molecules and can be utilized to assess how such changes influence antigen presentation, T-cell activation, and overall immune responses. Using these cell lines, researchers can dissect complex networks of gene regulation and better understand the role of RFX2 in pathologies ranging from autoimmune diseases to cancer.
In research and clinical settings, RFX2 Gene Knockout Cell Lines present significant advantages over conventional models. They provide a reproducible and highly relevant platform for elucidating the gene’s effects, enabling exploration of therapeutic targets and biomarker discovery. Unlike alternative approaches that rely on transient knockdown methods, the stable knockout allows for long-term studies and more reliable data.
For researchers and clinicians seeking to deepen their understanding of immune mechanisms or develop novel therapeutic strategies, these cell lines are invaluable tools. The ability to manipulate the genetic landscape of these cells opens up new avenues of investigation that can lead to breakthroughs in disease treatment.
Our company specializes in the development of high-quality biological products that empower researchers globally. With a commitment to innovative solutions and scientific rigor, we aim to provide exceptional resources to enhance your research and clinical efforts.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.